Channing Der and his wife, Kathy, had already planned a 30th wedding anniversary trip to Kenya. After hearing Carolina alumnus and author Rye Barcott talk about his book, It Happened on the Way to War: A Marine’s Path to Peace, and describe the Carolina for Kibera program in Nairobi, Kenya, they knew they had to see the program in action.
Toolkit moves best practices to the community
Chapel Hill - A team of UNC scientists report that in laboratory studies, overexpression of a specific protein could be used as a prognostic marker and as a guide for therapeutic choices for patients with head and neck cancer. Their findings appear in the September 9, 2011 online issue of the journal Clinical Cancer Research.
CHAPEL HILL – When sperm meets egg, the chemical instructions that tag sperm cells must be erased so that human life can start anew. One way these instructions are erased is through demethylation, the removal of specific chemical tags or methyl groups that dot the underlying DNA of cells. Though scientists have known about this phenomenon for a decade, exactly how such “reprogramming” occurs has proved elusive.
Chapel Hill - A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor of Chemistry and Pharmacy, and colleagues report their finding online in advance of print on September 14, 2011 in Angewandte Chemie, the German-based flagship chemistry journal.
CHAPEL HILL, N.C. – Weili Lin, PhD, professor of radiology, neurology and biomedical engineering and director of the UNC Biomedical Research Imaging Center, has been appointed The Dixie Lee Boney Soo Distinguished Professor in Neurological Medicine.
CHAPEL HILL – A team of over 250 researchers from more than 20 countries have discovered that common genetic variations contribute to a person’s risk of schizophrenia and bipolar disorder.
CHAPEL HILL – Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body’s own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.
Seventh annual event benefits cancer research and treatment in our community
Two recent grants from the National Science Foundation will support soft matter research at the University of North Carolina at Chapel Hill.
Kevin Weeks, a chemist at the University of North Carolina at Chapel Hill, has received an award from the National Institutes of Health to support innovative research on creating new drugs that work by binding to RNA.
UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.
Two UNC Lineberger faculty, Noel Brewer, PhD, associate professor of health behavior and health education in the UNC Gillings School of Global Public Health, and Karen Mohlke, PhD, associate professor of genetics in the UNC School of Medicine, have received the 2011 Hettleman Prize for Artistic and Scholarly Achievement by Young Faculty at UNC-Chapel Hill.
Chapel Hill - Deciding whether or not to have breast reconstruction after mastectomy is highly challenging for many patients. Clara Lee, MD, MPP, a UNC School of Medicine physician/scientist, has received a five-year grant award to examine patients’ decision-making process about reconstruction and the effects of reconstruction on quality of life and body image. The $862,700.00 career development award to the plastic and reconstructive surgeon is from the National Institutes of Health.
Peer Connect provides training for cancer survivors who wish to "give back" by talking with or being a buddy to another patient or survivor. Peer Connect meets a need for more formalized training for the "guides" or peer counselors by teaching effective communication skills and strategies based on Motivational Interviewing (MI), which focuses on listening and meeting the needs of the recipient rather than giving advice or telling people what to do.
Chapel Hill, NC – Lawrence B. Marks, MD, chairman of the UNC Department of Radiation Oncology, has been appointed the Dr. Sidney K. Simon Distinguished Professor of Oncology Research at UNC-Chapel Hill. The professorship, established by a $500K gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas, is named in honor of Mr. Loewenbaum’s grandfather, Dr. Sidney K. Simon.
Wizdom Powell Hammond, PhD, assistant professor of health behavior and health education at UNC Gillings School of Global Public Health, has been named to the 2011-2012 class of White House Fellows, the White House recently announced.
Susan McKenney, APRN, BC, MSN, OCN, Clinical Associate Professor of Surgery, has been selected by NBC 17, along with Chapel Hill and Durham magazines, as a Super 17 Nurse.
Chapel Hill, NC – Stefanie Sarantopoulos, MD, PhD, was recruited to UNC in 2009 with the help of the University Cancer Research Fund. Now she is a recipient of two grants that have helped establish her own laboratory to look into the causes of chronic Graft vs. Host Disease. Sarantopoulos is an Assistant Professor of Medicine in the Division of Hematology/Oncology and Microbiology and Immunology and a member of UNC Lineberger Comprehensive Cancer Center.
Hyundai Hope on Wheels and Raleigh-Durham Area Hyundai Dealers today awarded Ian Davis, MD, PhD, a $100,000 grant to support research into the causes of and treatments for pediatric sarcoma. Davis, assistant professor of pediatrics and genetics and a member of UNC Lineberger Comprehensive Cancer Center is one of 71 recipients of Hyundai Hope on Wheels’ 2011 Hope Grant program, where $7.1 million will be awarded to support research and programs in honor of National Childhood Cancer Awareness Month.
Men who are 40 years old or older, or who have a family history of prostate cancer, may make an appointment in advance by calling 919-966-1316. Walk-ins are also accepted.
The UNC Comprehensive Cancer Support Program is sponsoring a monthly community educational series called “Cancer Conversations.” Featuring UNC physicians and others, the series is a time intended to help people learn from and talk with cancer experts. The sessions will be held the third Tuesday of each month from 7:00 – 8:30 pm: September 20, October 18, November 15 (no session in December).
Close to 40 participants braved Hurricane Irene to learn how to be effective advocates for lung cancer.
CHAPEL HILL, N.C. It takes life-saving research to Conquer Kids’ Cancer! The St. Baldrick’s Foundation, a volunteer-driven charity dedicated to raising money for childhood cancer research, has awarded a $330,000 St. Baldrick’s Scholar award to Timothy Gershon, MD, PhD, and assistant professor of neurology at the School of Medicine at the University of North Carolina at Chapel Hill.
Chapel Hill - A UNC-led study has shown the potential for nanotechnology therapy for ovarian cancer. Scientists at UNC Lineberger Comprehensive Cancer Center and Duke University Medical Center conducted a preclinical study using nanoparticle technology to deliver doses of chemo- and radiotherapy that specifically targeted metastasized ovarian cancer cells, eradicating the cancer and lessening the toxicities often associated with the treatment.